Abstract: Vanadium (IV) complexes containing a substituted or unsubstituted catecholate ligand, and the spermicidal activity of such compounds. Preferred compounds are vanadocene (IV) complexes containing alkyl substituted catecholate ligands.

Abstract: The luminescent platinum 1,2-enedithiolates are dual emitters with a short-lived 1ILCT* singlet and long-lived oxygen-sensing 3ILCT* triplet (ILCT; intraligand charge transfer transition) emissive excited states. Since only the triplet is quenched by molecular oxygen, the singlet serves as an internal standard for dioxygen measurements. This allows the concentration of dioxygen to be determined from the ratio of the singlet/triplet emissions. The novel dual emitters are readily polymer encapsulated to allow measurement of dioxygen in a range of settings. These polymer encapsulated dual emitters will serve as a drop-in step-out replacement sensor for currently available dioxygen measuring devices.

Abstract: Compounds of the following formula are suitable as activators for peroxy compounds in laundry detergents and cleaning products: [LnMmXp]zYq  (1) in which M is manganese in oxidation stage II, III, IV, V and/or VI or cobalt in oxidation stage II and/or III, X is a coordination group or bridging group, Y is a counterion in the corresponding stoichiometric amount to balance a charge z present, where z as the metal complex charge, can be positive, zero or negative, n and m, independently of one another, are integers of from 1 to 4, p is an integer from 0 to 15, q is z/charge of Y L is a ligand of the formula (2) in which substituents R1 to R8 are as defined in the description.

Abstract: The present invention provides a process for preparing a polyaromatic compound comprising at least one sequence of two aromatic rings. The process of the invention, which consists in reacting an aromatic compound bearing a leaving group and an arylboronic acid and/or its derivatives in the presence of a base and an effective amount of a nickel catalyst, is characterized in that the reaction is conducted in a reaction solvent which is water optionally in a mixture with an organic solvent and in the presence of an effective amount of a catalyst based on nickel with at least one water-soluble phosphine ligand.

Abstract: The present invention provides a bis(2-pyridinethiol-1-oxide) copper salt coated with one or more compounds selected from glycerin, dialkyl phthalate, lubricating oil, acrylic resin, rosin, fatty acid amide, dialkyl polysulfide, polybutene, paraffin and petrolatum. The coated copper salt does not scatter, so that it is easy to handle, and is superior in safety and workability. In addition, the copper salt does not suffer from any adverse influence on the inherent storage stability or antifouling effect by being coated. Therefore, a coating for the bottom of a ship having a superior antifouling effect and storage stability can be obtained.

Abstract: Novel sulfur-containing ligands for binding of heavy metals are disclosed. The ligands incorporate a central ring structure and pendant alkyl-thiol chains. The ligands are of the general structure: where n is an integer from 1-4, and X is selected from the group consisting of hydrogen, lithium, sodium, potassium, rubidium, cesium, and francium. The ligands of the present invention are suitable for binding any metal in or capable of being placed in a positive oxidation state, such as cadmium, lead, nickel, zinc, mercury, copper, and the like. Additionally, methods for removal of heavy metals from various substances are disclosed, comprising separating selected heavy metals from selected substances by contacting the substances with an effective amount of the novel sulfur-containing chelate ligands for a sufficient time to form stable, irreversible ligand-metal precipitates, and removing such precipitates.

Abstract: The present invention relates to a single-pot process for the preparation of metal nicotinates, useful as a dietary supplement, from beta picoline as a source of the starting material, said process comprising the steps hydrosulfonation of beta picoline with sulfuric acid, heating the reaction mixture thus obtained to a temperature of about 150°-210° C. followed by oxidation with a suitable oxidizing agent to obtain nicotinic acid sulfate, reacting the nicotinic acid sulfate with a water soluble zinc and/or chromium salt to produce a solid metal nicotinate and separating it to thereby recover the corresponding metal nicotinates of high purity.

Abstract: Vanadium (IV) complexes containing a substituted or unsubstituted catecholate ligand, and the spermicidal activity of such compounds. Preferred compounds are vanadocene (IV) complexes containing alkyl substituted catecholate ligands.

Abstract: A metal complex and its use for binding or cleaving a nucleic acid. The metal complex has the formula: M is Pt, Pd, Ni, Co, or Cu; X is aryl, heteroaryl, cyclyl, or heterocyclyl; Y is halogen, tosylate, mesylate, triflate, pyrophosphate, or carboxylate; each of A1 and A2, independently, is N or C; each of A3 and A4, independently, is N, S, or 0, wherein A1, A2, A3, and A4 taken together have one positive charge; and each of R1 and R2, independently, is alkyl, aryl, heteroaryl, alkoxyl, aryloxyl, heteroaryloxyl, alkoxylcarbonyl, aryloxylcarbonyl, or heteroaryloxylcarbonyl.

Abstract: The invention provides methods for treating cancer and vanadium compounds that are useful for the treatment of tumors, as well as pharmaceutical compositions comprising the compounds, and synthetic methods and intermediates useful for preparing the compounds.

Abstract: A series of compounds in the 4-fluoroalkyl-3-halophenyl nortropanes and 4-haloethenylphenyl tropane families are described as diagnostic and therapeutic agents for diseases associated with serotonin transporter dysfunction. These compounds bind to serotonin transporter protein with high affinity and selectivity. The invention provides methods of synthesis which incorporate radioisotopic halogens at a last step which permit high radiochemical yield and maximum usable product life. The radiolabeled compounds of the invention are useful as imaging agents for visualizing the location and density of serotonin transporter by PET and SPECT imaging.

Abstract: Penta- and hexa-coordinated, bridged ruthenium and osmium catalysts of the formula wherein Me is ruthenium or osmium; L1 and L2 are neutral ligands having electron donor properties; X is an anionic ligand; Y is oxygen or sulphur; A is a direct bond, C1-C4alkylene or C2-C4alkylidene; Z is a direct bond, oxygen, sulphur or the groups wherein R1 and R2 are hydrogen or hydrocarbon radicals; their preparation and their us in the synthesis of polymers, in the ring-closure metathesis of diolefins, in the cross metathesis of olefins and in the isomerisation of olefins are disclosed.

Abstract: A compound of the formula

Abstract: Novel compounds having one group 13 element bound with one mono- or di-anionic tridentate ligand, a method of preparation thereof and use thereof as a copolymerization catalyst.

Abstract: A 6,13-dihydroquinacridone derivative of formula I:

Abstract: Organic complexes of vanadium are provided, having the general structure VL3, where V is vanadium(III) and L is a monoprotic bidentate ligand that forms a five-membered, unsaturated vanadium containing ring, having vanadium coordinating oxygen or sulfur ring heteroatoms, and where the vanadium containing ring is fused to a six-membered heterocyclic ring. Preferably L is a hydroxypyrone or a hydroxypyridinone. The complexes have a number of uses, including the treatment of elevated blood glucose and related disorders, treatment of proliferative disorders, etc.

Abstract: Organovanadium complexes, and more specifically hydroxyoxovanadium(V), &mgr;-oxo dimeric oxovanadium(V) and cis-dioxovanadium(V) complexes, are provided. The complexes may be formulated into a pharmaceutical composition. The complexes and/or compositions may be used in the treatment of a variety of disease states, including use as anti-proliferative and/or anti-metastatic agents and/or to treat drug resistant tumors and/or to methods of reducing the ability of tumors to metastasize and/or for the treatment of diabetes, arthritis, multiple sclerosis, diseases involving passageways of the body, and autoimmune diseases including but not limited to psoriasis and lupus.

Abstract: A salt of an anionic complex of Ru(III) with an ammonium cation fof formula (I), where R1, R2 and R3, equal or different from each other, are selected from the group consisting of H, C1-C6 alkyl, linear or branched, saturated or unsaturated, C3-C7 cycloalkyl, phenyl and aryl; or NR1R2R3 is a 5-7-membered nitrogen-containing heterocycle, saturated or unsaturated, optionally containing one or more O, S and/or N atoms, said nitrogen atom being optionally substituted with a C1-C4 alkyl, aryl or benzyl residue; said nitrogen-containing heterocycle being optionally condensed with a benzo group and/or substituted with C1-C4 alkyl, C1-C4 alkoxyl, C1-C4 alkylthio, aryl or benzyl groups; where R4 and R5, equal or different from each other, are selected from the group consisting of H, C1-C6 alkyl, C3-C7 cycloalkyl, phenyl and aryl or R4 and R5 form, together with the S atom, a 4-7-membered heterocycle.

Abstract: Compounds of the following formula are suitable as activators for peroxy compounds in laundry detergents and cleaning products:[L.sub.n M.sub.m X.sub.p ].sup.z Y.sub.q (1)in whichM is manganese in oxidation stage II, III, IV, V and/or VI or cobalt in oxidation stage II and/or III,X is a coordination group or bridging group,Y is a counterion in the corresponding stoichiometric amount to balance a charge z present, wherez as the metal complex charge, can be positive, zero or negative,n and m, independently of one another, are integers of from 1 to 4,p is an integer from 0 to 15,q is z/charge of YL is a ligand of the formula (2) ##STR1## in which substituents R.sup.1 to R.sup.8 are as defined in the description.

Abstract: A catalyst composition for the polymerization of olefins is provided, comprising a bis(hydroxy aromatic nitrogen ligand) transition metal catalyst precursor and an activating cocatalyst.

Abstract: Novel chiral boron and aluminum hydride complexes, compositions comprising the chiral hydride complexes, and methods for their synthesis and use are described. The novel chiral hydride complexes are of the formulas:MBH.sub.4-n-a (R*).sub.n (R').sub.a ;MBH.sub.2-b (R**) (R').sub.b ;MBH(R***);MBH(R*) (R");MAlH.sub.4-n-a (R*).sub.n (R').sub.a ;MAlH.sub.2-b (R**)(R').sub.b ;MAlH(R***); andMAlH(R*) (R"),whereinM is Na.sup.+, Li.sup.+ or K.sup.+ ;each R* is independently a monodentate chiral ligand;R** is a bidentate chiral ligand;R*** is a tridentate chiral ligand;R' is a monodentate achiral ligand;R" is a bidentate achiral ligand;n is 1-3;a is 0-2; andb is 0-1,with the proviso that n+a.ltoreq.3, and with the further proviso that when R** is S-BINOL, M is not Li.sup.+.

Abstract: A method of treating neoplastic disease wherein a patient in need of such treatment is administered an effective amount of a radiation-activated cytotoxin prodrug (RACP) which has low toxicity, which is reducible by reducing agents generated by the radiolysis of water and which, upon reduction, releases a sufficient amount of a cytotoxic effector of sufficient cytotoxic potency to kill tumor cells. The tumor cells are irradiated with ionizing radiation to reduce the prodrug which is present at the locus of the tumor cells to release the cytotoxic effector.

Abstract: In one of its aspects, the invention relates to compounds of formula I ##STR1## M is Eu, Tb or Dy, Sm; R.sub.2 is hydrogen or C.sub.1 -C.sub.6 alkyl, andR.sub.1 and R.sub.3 are each independently of the other phenyl, hydrogen or C.sub.1 -C.sub.6 alkyl, andL is p-N,N-dimethylaminopyridine, N-methylimidazole or p-methoxypyridine-N-oxide.The invention also relates to the use of these compounds for optical sensors sensitive to impact, tension or pressure.

Abstract: The present invention relates to a method for producing submicron-sized particles of pyrithione salts, comprising reacting pyrithione or a water-soluble salt of pyrithione and a water-soluble polyvalent metal salt in a pressurized turbulent flow reactor that generates pulverizing forces, the reaction producing submicron sized particles of pyrithione salt. The present invention also relates to particles made by the above method, and products, such as shampoos, soaps, and skin care medicaments made using these particles.

Abstract: The present invention relates to the treatment of tumors with a novel water soluble trans-platinum coordination compound having the general structural formula [PtBX.sub.m (NR*.sub.3)] where B is a planar, heterocyclic ring containing at least one nitrogen atom, and a pendant chelating group; and X is an anionic ligand; and R* is hydrogen or a lower alkyl.

Abstract: The present invention relates to novel metal chelates, exemplified as technetium-99m or rhenium chelates, and to the process of preparing such metal chelates from corresponding ligands. These ligands and their corresponding metal chelates are synthesized to have a cysteinylethylene (EC) structure, a monothiourea (MTU) structure, or a dithiourea (DTU) structure. The present invention further relates to a pharmaceutical composition comprising a metal chelate, for example, a .sup.99m Tc-chelate, to the use of the composition for renal imaging and examination of renal function, and to a kit for preparing such a composition prior to use.

Abstract: A phenanthridine derivative metal complex of formula 1 having a large absorption in the near-infrared range and a reduced absorption in the visible range, which phenanthridine derivative metal complex is used in a transparent recording medium: ##STR1## where M is a metal atom, and X is a negative ion.

Abstract: An acridine derivative metal complex of formula 2 having a large absorption in the near-infrared range and a reduced absorption in the visible range, which acridine derivative metal complex is used in a transparent recording medium: ##STR1## where M is a metal atom, and X is a negative ion.

Abstract: Disclosed is a series of improved chelating agents and the chelates formed from these agents, which are highly effective upon both injection and oral administration. Several of the most effective are of low toxicity. These chelating agents incorporate within their structure 3-hydroxy-2-pyridinone (3,2-HOPO) moieties with a substituted carbamoyl group ortho to the hydroxy group of the hydroxypyridinone ring. The electron-withdrawing carbamoyl group increases the acidity, as well as the chemical stability towards oxidation and reduction, of the hydroxypyridinones. In the metal complexes of the chelating agents, the amide protons form very strong hydrogen bonds with the adjacent HOPO oxygen donor, making these complexes very stable at physiological conditions. The terminal N-substituents provide a certain degree of lipophilicity to the 3,2-HOPO, increasing oral activity.

Abstract: The present invention is drawn to complexes of dibenzyl-organotin compounds having nitrogen or sulfur containing heterocyclic ligands. Said complexes are useful as cytotoxic agents.

Abstract: A novel trivalent Group IVB metal complex for preparing syndiotactic vinyl aromatic polymers is disclosed which is coordinated by a bidentate ligand and is represented by the formula (I):(C.sub.5 R.sub.n H.sub.5-n)M(BD).sub.m Y.sub.p (I)wherein C.sub.5 R.sub.n H.sub.5-n is a substituted or unsubstituted cyclopentadienyl group, n is an integer between 0 and 5, and R is C.sub.1 to C.sub.12 alkyl, aryl, substituted alkyl, or substituted aryl; M is a trivalent Group IVB metal; (BD) is a bidentate ligand with -1 valence, having a coordinating group which is capable of forming a coordinating bond or a chelating bond with the metal M; Y is selected from the group consisting of alkyl, aryl, aralkyl, halogen and hydrogen; m is an integer of 1 or 2; and m+p=2.

Abstract: This invention relates to a detectable molecule comprising a biospecific binding reactant attached to a luminescent lanthanide chelate comprising a lanthanide ion and a chelating ligand of the formula ##STR1## wherein --A-- is a bivalent aromatic structure selected from the group consisting of ##STR2## One of the two groups G.sub.1 or G.sub.2 is used for coupling the chelate to a biospecific binding reactant. The lanthanide ion is europium(III), terbium(III), dysprosium (III) or samarium (III).

Abstract: A catalyst composition for the polymerization of olefins is provided, comprising a bis(hydroxy aromatic nitrogen ligand) transition metal catalyst precursor and an activating cocatalyst.

Abstract: Aluminum amidinate compounds of the formula ##STR1## wherein R.sup., R.sup.2, and R.sup.3 are selected from the group consisting of C.sub.1 to C.sub.50 alkyl, aryl, and silyl groups, X is an anionic ligand, preferably a hydrocarbyl, n=0 or 1, L, if present, is a labile Lewis base ligand, preferably having an oxygen, nitrogen, or phosphorus atom donating a lone pair of electrons to the aluminum center, and A.sup.- is an anion which balances the charge of the aluminum cation and only weakly if at all coordinates to the aluminum center and preferably contains boron, are disclosed. These compounds are useful as olefin polymerization catalysts without the need for cocatalysts or transition metal species.

Abstract: A compound of formula I ##STR1## X is O or S; A is 6-alkoxy-3-pyridyl optionally substituted by halogen;Y is hydrogen or alkyl;R.sup.3 is alkyl or a metal salt complex thereof. This invention contains fungicidal compositions and are used to combat cytopathogenic fungi.

Abstract: Compounds having the formula ##STR1## wherein each A may be the same or different and is an alkyl group, a phenyl group or a substituted derivative of a phenyl group;Y may be the same or different and is hydrogen, an unbranched alkyl group, a halide or a group having the structure ##STR2## wherein R is hydrogen, an alkoxide group, an alkyl group, or OH; B may be the same or different and each is hydrogen or an alkyl group;Z.sup.- is a soluble, pharmaceutically acceptable negative ion, andX may be the same or different and is an axial ligand selected from the group consisting of moieties having the formula: ##STR3## The compounds and compositions thereof exhibit antiviral activity.

Abstract: A process is described for inhibiting the re-absorption of migrating dyes in the wash liquor, comprising introducing into a wash liquor containing a peroxide-containing detergent, from 0.5 to 150, preferably from 1.5 to 75, especially from 7.5 to 40 mg, per liter of wash liquor, of one or more compounds having the formula (1), (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13) or (14) as defined in the specification. The compounds of formula (1), (2), (3), (4), (5), (6), (8), (9) (10), (11), (12), (13) or (14) are new compounds. The compounds used do not exhaust at all on to cotton, polyamide or polyester fibers, so that the compounds cannot lead to fiber discoloration problems.

Abstract: Stable silylenes, and analog carbenes are prepared.

Abstract: Novel pyridine phosphonate ligands are disclosed that when combined with polyvalent metals results in useful catalyst compositions for the conversion of hydrogen sulfide to solid sulfur. Catalysts containing these novel ligands exhibit resistance to metal precipitation and demonstrate little or no oxidative chemical degradation when employed to convert hydrogen sulfide to elemental sulfur.

Abstract: Novel 2-chloro and 2-bromo derivatives of 1,5-iminosugars are disclosed, especially such derivatives of 1,5-dideoxy-1,5-imino-D-glucitol. These compounds are useful inhibitors of glucosidase enzymes and also are useful as antiviral agents and as intermediates for the synthesis of other enzyme inhibitors and antiviral compounds.

Abstract: The present invention relates to a process for producing a gel-free dispersion or solution of copper pyrithione employing at least one surfactant. Also claimed is the dispersion or solution itself, as well as a solid particulate copper pyrithione composition comprising copper pyrithione particles having a particle shape selected from the group consisting of rods, spheres, needles, platelets and combinations thereof, and optionally containing at least a trace amount of a surfactant on the outer surface of at least a portion of said particles.

Abstract: Novel pyrazole-containing compounds useful as light-stabilizers for polymers, their Ni, Zn, Cu, and Co metal complexes, and methods for the synthesis of such complexes are provided. The compounds include a hindered amine light stabilizer (HALS) such as a substituted piperidine, thereby incorporate the properties of UV absorbers and redical scavengers. The compounds are of the formulas I and II, ##STR1## where R.sub.1 is phenyl, R.sub.2 is methyl, X is oxygen or sulphur, Z is oxygen or N-aryl, and R.sub.3 is hydrogen, alkyl, a derivative of carboxyacryloyl or carboxybenzoyl or a derivative of pyrazole. The compounds and their metal complexes are highly compatible with various polymers, thermostable, and retain their photostability under conditions of continuous and intensive irradiation. Methods for the synthesis of metal complexes include the reaction of: (a) a compound with metal acetate; or (b) a metal complex with anhydride or a pyrazole derivative.

Abstract: Novel 2-chloro and 2-bromo derivatives of 1,5-iminosugars are disclosed, especially such derivatives of 1,5-dideoxy-1,5-imino-D-glucitol. These compounds are useful inhibitors of glucosidase enzymes and also are useful as antiviral agents and as intermediates for the synthesis of other enzyme inhibitors and antiviral compounds.

Abstract: Lanthanide chelates which contain three heterocyclic rings covalently coupled to each other (either one 2,6-pyridylene and two five-membered unsaturated heterocyclic ring moieties or two 2,6-pyridylene and one five-membered unsaturated heterocyclic ring moiety) and two chelating groups so seated that they together chelate the same lanthanide ion even in aqueous solutions. These lanthanide chelates can optionally contain a reactive group for coupling to biologically active molecules. The new chelates are suitable for classical lanthanide chelate applications and are also useful as probes in time-resolved fluorescence microscopy, cytometry, multilabelling techniques and in process controls in industry.

Abstract: The present invention relates to a process for producing a gel-free dispersion or solution of copper pyrithione employing at least one surfactant. Also claimed is the dispersion or solution itself, as well as a solid particulate copper pyrithione composition comprising copper pyrithione particles having a particle shape selected from the group consisting of rods, spheres, needles, platelets and combinations thereof, and optionally containing at least a trace amount of a surfactant on the outer surface of at least a portion of said particles.

Abstract: A photostable cyanine dye possessing a structure represented by the general formula I or II:.PHI..sup.+ -L=.PSI..multidot.Q.sup.- (I).PHI.=L-.PSI..sup.+ .multidot.Q.sup.- (II)wherein .PHI. denotes a monovalent or divalent residue of thiazole ring, oxazole ring, selenazole ring, imidazole ring, pyridine ring, indolenine ring, benzoindolenine ring or dibenzoindolenine ring which may have an aromatic ring condensed thereto, .PSI. denotes a divalent or monovalent residue of thiazole ring, oxazole ring, selenazole ring, imidazole ring, pyridine ring, indolenine ring, benzoindolenine ring or dibenzoindolenine ring which may have an aromatic ring condensed thereto, L denotes a polymethine connecting group for the formation of a cyanine dye, and Q.sup.- denotes an anion represented by the general formula III: ##STR1## wherein M denotes a transition metal atom, R.sup.1, R.sup.2, R.sup.3 and R.sup.

Abstract: An organic electroluminescence device having excellent properties of high luminance, high efficiency of light emission and long life and a novel compound having an aluminum complex structure used as a component in said device are disclosed. The invention provides an organic electroluminescence device comprising a compound having an aluminum complex structure represented by the general formula (I): ##STR1## wherein X indicates --Ar.sup.1 --Y--Ar.sup.2 -- or an aryl- or alkylsilylene group, Ar.sup.1 and Ar.sup.2 indicate each an aromatic ring, Y indicates an alkylene group, a cycloalkylene group, an alkylidene group, a cycloalkylidene group, --CO--, --O--, --S-- or the like and L.sup.1 to L.sup.4 indicate each a ligand, such as a substituted or unsubstituted 8-quinolyloxy group or the like. The invention also provides a compound having an aluminum complex structure described above.

Abstract: Novel perylene compounds based on perylene-3,4,9,10-tetracarboxylic acid monoanhydride monoimides which are substituted by alkylene- or arylenesulfonic acid groups on one or both imide nitrogen atoms, or on corresponding tetracarboxylic acid diimides, or on a halogenation product thereof, have properties which render them accessible, in addition to their use as dispersing agent for pigments of the same class of compound or other categories, also for direct use as pigments and fluorescent dyestuffs as well as polymer-soluble dyestuffs.

Abstract: A composition which contains a 4,5-polymethylene-4-isothiazolin-3-one and a salt or complex of 2-mercaptopyridine-1-oxide with a metal which is at least divalent. The salt or complex is typically zinc 2-thiopyridine-1-oxide. The compositions exhibit anti-microbial activity and certain combinations of isothiazolinones together with zinc 2-thiopyridine-1-oxide are surprisingly effective against both bacteria and fungi.

Abstract: Pharmaceutical compositions containing an iron complex of a 3-hydroxypyrid-2-one or 3-hydroxypyrid-4-one in which the hydrogen atom attached to the nitrogen atom is replaced by an aliphatic acyl group, by an aliphatic hydrocarbon group, or by an aliphatic hydrocarbon group substituted by one or, except in the case of ionizable groups, more than one substituent selected from aliphatic acyl, alkoxy, aliphatic amine, aliphatic amide, carboxy, aliphatic ester, halogen, hydroxy and sulpho groups and, optionally, in which one or more of the hydrogen atoms attached to ring carbon atoms are replaced by one of said substituents, by an aliphatic hydrocarbon group, or by an aliphatic hydrocarbon group substituted by an alkoxy, aliphatic ester, halogen or hydroxy group, but excluding compounds in which said replacement of hydrogen atoms in the compound is effected only by aliphatic hydrocarbon groups, are of value for the treatment of iron deficiency anemia.